Renovia is a women’s health start-up that was founded by Marc Beer in 2016. Marc has been working in the health industry primarily the pharmaceutical sector as an executive for 25 years. He has specialized in the development and commercialization of pharmaceutical products. This well-experienced pharmaceutical professional was following his passion for using his skills to save lives when he founded Renovia. Marc recently announced that his start-up would be making releasing four new products soon. This announcement came in light of him successfully raising $42 million to fund his company.
Four new products in the works
Renovia’s primary goal was to find remedies and solutions to women’s health problems and specifically pelvic disorders. Pelvic disorders according to statistics affect at least 250 million women currently all over the world. As a result of these disorders the most common of which is urinary inconsistencies, the affected women are living a life of despair. Last April, the FDA approved the first medical product from Marc Beer’s start-up, the Leva device. The Leva device was designed as a solution that will afford women living with urinary inconsistencies a relief.
Among the four new products that Marc Beer hinted were in the works is the new generation Leva device. The new generation of the device will be improving on the design and function of the first device. The Renovia boss hinted that the new device would be looking to make its usage as simple as it can be. In addition to this, the new generation Leva device will cost much less and therefore more women around the world can be able to afford it.
In his announcement, Beer mentioned that $32 million of the total amount he had raised was from Series B round investors. $10 million of the total amount he had raised was from venture capital. The Renovia boss took some time in his speech to celebrate the new investors who had joined his company. The stated that the confidence they had shown for his company was quite inspiring. The new investors were Ascension Ventures from Missouri and Perceptive Advisors from New York. One of Renovia’s earliest investors, The Longwood Fund was also part of this Series B round. This particular investor only makes investments in the pharmaceutical sector and has shown a lot of trust in Beer’s start-up.
About Marc Beer
Marc Beer is one of the most iconic executives in the pharmaceutical sector. His career as a specialist in the development and commercialization of medical products has given him a chance to save millions of lives all over the globe. According to Beer, his start-up Renovia is uniquely positioned to improve the lives of millions of women across the world, a responsibility they take seriously. Learn more: https://blogwebpedia.com/marc-beer-entrepreneurial-spirit-biotech.html#.XHg3cFNKiqQ